alcohol

topiramate v placebo for heavy drinking by genotype

In a 12 week study, heavy drinkers with the CC genotype at rs2832407 in the kainite receptor showed significant reductions in heavy drinking when treated with topiramate.

Those who have CC genotype in the kainite receptor DNA at rs2832407 benefit from topiramate treatment.